These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials. Ogoyama Y; Tada K; Abe M; Nanto S; Shibata H; Mukoyama M; Kai H; Arima H; Kario K Hypertens Res; 2022 Feb; 45(2):210-220. PubMed ID: 34657140 [TBL] [Abstract][Full Text] [Related]
29. The effects of renal denervation on resistant hypertension patients: a meta-analysis. Zhang X; Wu N; Yan W; Zhou C; Guo H Blood Press Monit; 2016 Aug; 21(4):206-14. PubMed ID: 26901340 [TBL] [Abstract][Full Text] [Related]
30. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study. Rosa J; Widimský P; Waldauf P; Lambert L; Zelinka T; Táborský M; Branny M; Toušek P; Petrák O; Čurila K; Bednář F; Holaj R; Štrauch B; Václavík J; Nykl I; Krátká Z; Kociánová E; Jiravský O; Rappová G; Indra T; Widimský J Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818 [TBL] [Abstract][Full Text] [Related]
31. Does renal artery supply indicate treatment success of renal denervation? Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326 [TBL] [Abstract][Full Text] [Related]
32. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248 [TBL] [Abstract][Full Text] [Related]
33. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578 [TBL] [Abstract][Full Text] [Related]
34. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials. Yao Y; Zhang D; Qian J; Deng S; Huang Y; Huang J Clin Exp Hypertens; 2016; 38(3):278-86. PubMed ID: 27018652 [TBL] [Abstract][Full Text] [Related]
35. Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension. Jacobs L; Persu A; Huang QF; Lengelé JP; Thijs L; Hammer F; Yang WY; Zhang ZY; Renkin J; Sinnaeve P; Wei FF; Pasquet A; Fadl Elmula FEM; Carlier M; Elvan A; Wunder C; Kjeldsen SE; Toennes SW; Janssens S; Verhamme P; Staessen JA; Blood Press; 2017 Dec; 26(6):321-331. PubMed ID: 28489464 [TBL] [Abstract][Full Text] [Related]
36. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention? Chen S; Kiuchi MG; Schmidt B; Hoye NA; Acou WJ; Liu S; Chun KRJ; Pürerfellner H Herz; 2019 Aug; 44(5):412-418. PubMed ID: 29255910 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. Davis MI; Filion KB; Zhang D; Eisenberg MJ; Afilalo J; Schiffrin EL; Joyal D J Am Coll Cardiol; 2013 Jul; 62(3):231-241. PubMed ID: 23644092 [TBL] [Abstract][Full Text] [Related]
38. Effect of Catheter-Based Renal Denervation on Uncontrolled Hypertension: A Systematic Review and Meta-analysis. Cheng X; Zhang D; Luo S; Qin S Mayo Clin Proc; 2019 Sep; 94(9):1695-1706. PubMed ID: 31402054 [TBL] [Abstract][Full Text] [Related]
39. Renal nerve stimulation: complete versus incomplete renal sympathetic denervation. Hoogerwaard AF; Adiyaman A; de Jong MR; Smit JJ; Heeg JE; van Hasselt BAAM; Elvan A Blood Press; 2021 Dec; 30(6):376-385. PubMed ID: 34647513 [TBL] [Abstract][Full Text] [Related]
40. Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. Mahfoud F; Weber M; Schmieder RE; Lobo MD; Blankestijn PJ; Persu A; Fischell TA; Parise H; Pathak A; Kandzari DE Am Heart J; 2021 Sep; 239():90-99. PubMed ID: 34052211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]